BG-12 Pill Shows Promise in Suppressing Multiple Sclerosis Relapses

Thursday, September 20, 2012 - 00:20 in Health & Medicine

Clinical trials indicate that BG-12, developed by Biogen Idec, may be safer and more effective than existing treatments for patients in the early stages of the disease.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net